Kailera Therapeutics, Inc.
KLRA
17 insider filings · Latest: Apr 20, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Apr 22 8:15 PM | RTW INVESTMENTS, LP10% Owner | Purchase | 500,000 | $16.00 | $8.0M | 10,776,820(I) | View → |
| Apr 20, 2026 | Apr 20 10:10 PM | BAIN CAPITAL INVESTORS LLC10% Owner | Purchase | 8,398,438 | $16.00 | $134.4M | 26,255,581(I) | View → |
| Apr 20, 2026 | Apr 20 10:08 PM | Adam KoppelDirector, 10% Owner | Purchase | 1,562,500 | $16.00 | $25.0M | 22,583,268(I) | View → |
| Apr 20, 2026 | Apr 20 10:01 PM | Bain Capital Life Sciences Investors, LLC10% Owner | Purchase | 1,562,500 | $16.00 | $25.0M | 22,583,268(I) | View → |
| Apr 20, 2026 | Apr 20 10:00 PM | Andrew T. KaplanDirector, 10% Owner | Purchase | 8,398,438 | $16.00 | $134.4M | 26,255,581(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Apr 22 8:15 PM | RTW INVESTMENTS, LP10% Owner | Conversion | 10,276,820 | — | 0(I) | View → |
| Apr 20, 2026 | Apr 22 10:03 AM | Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner | Conversion | 5,677,603 | — | 0(D) | View → |
| Apr 20, 2026 | Apr 20 10:10 PM | BAIN CAPITAL INVESTORS LLC10% Owner | Conversion | 17,857,143 | — | 0(I) | View → |
| Apr 20, 2026 | Apr 20 10:08 PM | Adam KoppelDirector, 10% Owner | Conversion | 21,020,768 | — | 0(I) | View → |
| Apr 16, 2026 | Apr 20 10:08 PM | Adam KoppelDirector, 10% Owner | Grant/Award | 38,300 | $16.00 | 38,300(D) | View → |
| Apr 20, 2026 | Apr 20 10:01 PM | Bain Capital Life Sciences Investors, LLC10% Owner | Conversion | 21,020,768 | — | 0(I) | View → |
| Apr 20, 2026 | Apr 20 10:00 PM | Andrew T. KaplanDirector, 10% Owner | Conversion | 17,857,143 | — | 0(I) | View → |
| Apr 16, 2026 | Apr 20 10:00 PM | Andrew T. KaplanDirector, 10% Owner | Grant/Award | 38,300 | $16.00 | 38,300(D) | View → |
| Apr 16, 2026 | Apr 20 9:19 PM | Paula CloghessyChief People Officer | Grant/Award | 120,000 | $16.00 | 60,000(D) | View → |
| Apr 16, 2026 | Apr 20 9:19 PM | Scott AkamineChief Legal Officer | Grant/Award | 120,000 | $16.00 | 60,000(D) | View → |
| Apr 16, 2026 | Apr 20 9:18 PM | Ronald C Renaud JRDirector, CEO & President | Grant/Award | 600,000 | $16.00 | 300,000(D) | View → |
| Apr 16, 2026 | Apr 20 9:14 PM | Paul D. BurgessChief Operating Officer & Chief Business Officer | Grant/Award | 200,000 | $16.00 | 100,000(D) | View → |
| Apr 16, 2026 | Apr 20 9:13 PM | John F MilliganDirector | Grant/Award | 38,300 | $16.00 | 38,300(D) | View → |
| Apr 16, 2026 | Apr 20 9:13 PM | Jamie Beth ColemanChief Commercial Officer | Grant/Award | 150,000 | $16.00 | 75,000(D) | View → |
| Apr 16, 2026 | Apr 20 9:10 PM | Martin MackayDirector | Grant/Award | 38,300 | $16.00 | 38,300(D) | View → |
| Apr 16, 2026 | Apr 20 9:08 PM | Scott M. WassermanChief Medical Officer | Grant/Award | 200,000 | $16.00 | 100,000(D) | View → |
| Apr 16, 2026 | Apr 20 9:05 PM | Christopher HiteDirector | Grant/Award | 38,300 | $16.00 | 38,300(D) | View → |
| Apr 16, 2026 | Apr 20 9:04 PM | Frank ClyburnDirector | Grant/Award | 38,300 | $16.00 | 38,300(D) | View → |
| Apr 16, 2026 | Apr 20 9:01 PM | Douglas W. PaganChief Financial Officer | Grant/Award | 200,000 | $16.00 | 100,000(D) | View → |